critics also contend that the strategy behind the commission was developed by the pharmaceutical industry, advancing the theory that the primary purpose of the commission was to recommend implementation of tmap based algorithms on a nationwide basis. tmap, which advises the use of newer, more expensive medications, has itself been the subject of controversy in texas, pennsylvania and other states where efforts have been made to implement its use.